| Dr Marlene Zetzer Shivers, MD | |
|
2415 Parkwood Dr, Brunswick, GA 31520-4722 | |
| (912) 466-2495 | |
| Not Available |
| Full Name | Dr Marlene Zetzer Shivers |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 39 Years |
| Location | 2415 Parkwood Dr, Brunswick, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801915871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 33236 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Care Systems, Inc. | 5890783179 | 10 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Tift Regional Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790280857 PECOS PAC ID: 5193619971 Enrollment ID: O20040212000064 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Mayo Clinic Health System In Waycross, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154745982 PECOS PAC ID: 0042124919 Enrollment ID: O20040308000639 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Gateway Behavioral Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558478214 PECOS PAC ID: 3173510237 Enrollment ID: O20040429000700 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Hospital Authority Of Jeff Davis County Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912902263 PECOS PAC ID: 4981692472 Enrollment ID: O20040504000404 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Community Health Care Systems, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932150422 PECOS PAC ID: 5890783179 Enrollment ID: O20040505000153 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Entity Name | Lookout Mountain Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790782431 PECOS PAC ID: 4880682822 Enrollment ID: O20040506000251 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marlene Zetzer Shivers, MD 267 N Harrington Rd, St Simons Island, GA 31522-5341 Ph: (912) 634-1753 | Dr Marlene Zetzer Shivers, MD 2415 Parkwood Dr, Brunswick, GA 31520-4722 Ph: (912) 466-2495 |
News Archive
ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.
A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
A group of Johns Hopkins trained physicians has started a crowdfunding campaign to create a start-up which produces cheap generic drugs.
A British national was charged today with extortion and tampering with consumer products for sending several adulterated food items – including baby formula contaminated with boric acid – to the Ralphs grocery chain and demanding $180,000 to prevent poisoned food from being placed on store shelves.
› Verified 8 days ago
Mr. David J Faulk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1606 Gloucester St, Brunswick, GA 31520 Phone: 912-265-0644 Fax: 912-265-0644 | |
Dr. Douglas Thurman Cooper, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 107 Drew Cir, Brunswick, GA 31525 Phone: 917-705-1222 | |
Lori A Trefts, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 Starling St., Suite 503, Brunswick, GA 31520 Phone: 912-466-5503 Fax: 912-466-5553 | |
Janet Ann Mohr, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1421 Lee St, Brunswick, GA 31520 Phone: 912-261-9229 | |
David Scott Deuser, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 Coastal Village Dr, Brunswick, GA 31520 Phone: 912-554-8510 Fax: 912-368-6844 | |
Dr. Robert E Holland, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 106 Shoppers Way Ste 115, Brunswick, GA 31525 Phone: 912-265-7660 Fax: 912-265-7858 | |
Dr. Phillip P Amodeo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 Starling St, Suite 503, Brunswick, GA 31520 Phone: 912-466-5503 Fax: 912-466-5553 |